Guarded LINCS/L1000 reversal of severe equine asthma recovers disease biology but no coherent non-steroidal reversal class
This study demonstrates that while severe equine asthma possesses a robust, cross-species-queryable transcriptomic signature, a guarded LINCS/L1000 computational reversal approach successfully filters out standard-of-care drugs but fails to identify a coherent class of non-steroidal therapeutic candidates, thereby validating the framework as a rigorous anti-circularity benchmark rather than a direct path to new drug nominations.